CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
gabapentin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00022074
NCT00022074N/ACompleted
CompareCT.gov

Control of Vasomotor Symptoms in Women Treated for Breast Cancer

Gary Morrow·interventional·Posted Jan 27, 2003·Updated Oct 15, 2015

In Brief

A clinical study evaluating gabapentin and quality-of-life assessment for Anxiety Disorder and 3 related conditions. Completed, across 18 sites.

Detailed Summary

RATIONALE: Gabapentin may be effective for the control of hot flashes. It is not yet known if gabapentin is effective in treating hot flashes. PURPOSE: Randomized clinical trial to study the effectiveness of gabapentin in controlling hot flashes in women who have breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety Disorder, Breast Cancer, Depression, Hot Flashes
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2003
Enrollment StartJul 1, 2001
Primary CompletionJun 1, 2005
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 23.4 years ago

Interventions

gabapentindrug

quality-of-life assessmentprocedure